Pinnacle Associates’s Regeneron Pharmaceuticals REGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $63.8M | Sell |
82,512
-1,229
| -1% | -$941K | 0.82% | 23 |
|
|
2025
Q4 | $64.6M | Sell |
83,741
-450
| -0.5% | -$306K | 0.83% | 23 |
|
|
2025
Q3 | $47.3M | Buy |
84,191
+15,265
| +22% | +$8.63M | 0.63% | 33 |
|
|
2025
Q2 | $36.2M | Sell |
68,926
-12,087
| -15% | -$6.75M | 0.52% | 44 |
|
|
2025
Q1 | $51.4M | Buy |
81,013
+18,550
| +30% | +$12.8M | 0.75% | 24 |
|
|
2024
Q4 | $44.5M | Sell |
62,463
-4,502
| -7% | -$3.78M | 0.6% | 30 |
|
|
2024
Q3 | $58.8M | Buy |
66,965
+611
| +0.9% | +$680K | 1% | 11 |
|
|
2024
Q2 | $69.7M | Sell |
66,354
-156
| -0.2% | -$151K | 1.09% | 15 |
|
|
2024
Q1 | $64M | Sell |
66,510
-455
| -0.7% | -$433K | 1.01% | 15 |
|
|
2023
Q4 | $58.8M | Sell |
66,965
-518
| -0.8% | -$427K | 0.99% | 11 |
|
|
2023
Q3 | $55.5M | Sell |
67,483
-2,712
| -4% | -$2.13M | 1.03% | 10 |
|
|
2023
Q2 | $50.4M | Sell |
70,195
-1,504
| -2% | -$1.16M | 0.88% | 16 |
|
|
2023
Q1 | $58.9M | Sell |
71,699
-1,291
| -2% | -$974K | 1.2% | 6 |
|
|
2022
Q4 | $52.7M | Sell |
72,990
-527
| -0.7% | -$389K | 1.15% | 7 |
|
|
2022
Q3 | $50.6M | Sell |
73,517
-15,171
| -17% | -$9.55M | 1.16% | 6 |
|
|
2022
Q2 | $52.4M | Sell |
88,688
-3,013
| -3% | -$1.96M | 1.14% | 6 |
|
|
2022
Q1 | $64M | Sell |
91,701
-3,794
| -4% | -$2.4M | 1.13% | 8 |
|
|
2021
Q4 | $60.3M | Sell |
95,495
-1,424
| -1% | -$876K | 1.04% | 14 |
|
|
2021
Q3 | $58.7M | Sell |
96,919
-2,462
| -2% | -$1.53M | 1.08% | 14 |
|
|
2021
Q2 | $55.5M | Sell |
99,381
-1,110
| -1% | -$562K | 1% | 15 |
|
|
2021
Q1 | $47.5M | Sell |
100,491
-5,344
| -5% | -$2.6M | 0.91% | 19 |
|
|
2020
Q4 | $51.1M | Sell |
105,835
-4,885
| -4% | -$2.64M | 1.04% | 16 |
|
|
2020
Q3 | $62M | Sell |
110,720
-2,156
| -2% | -$1.31M | 1.47% | 9 |
|
|
2020
Q2 | $70.4M | Sell |
112,876
-6,970
| -6% | -$3.96M | 1.74% | 5 |
|
|
2020
Q1 | $58.5M | Sell |
119,846
-21,943
| -15% | -$9.05M | 1.78% | 5 |
|
|
2019
Q4 | $53.2M | Sell |
141,789
-13,171
| -8% | -$4.43M | 1.17% | 11 |
|
|
2019
Q3 | $43M | Sell |
154,960
-6,944
| -4% | -$2.05M | 1.01% | 16 |
|
|
2019
Q2 | $50.7M | Sell |
161,904
-9,312
| -5% | -$3.1M | 1.19% | 14 |
|
|
2019
Q1 | $70.3M | Sell |
171,216
-6,236
| -4% | -$2.57M | 1.59% | 6 |
|
|
2018
Q4 | $66.3M | Sell |
177,452
-12,699
| -7% | -$4.65M | 1.71% | 3 |
|
|
2018
Q3 | $76.8M | Sell |
190,151
-22,689
| -11% | -$8.64M | 1.59% | 5 |
|
|
2018
Q2 | $73.4M | Sell |
212,840
-28,203
| -12% | -$8.82M | 1.51% | 6 |
|
|
2018
Q1 | $83M | Sell |
241,043
-3,715
| -2% | -$1.29M | 1.63% | 6 |
|
|
2017
Q4 | $92M | Sell |
244,758
-19,349
| -7% | -$7.84M | 1.77% | 5 |
|
|
2017
Q3 | $118M | Sell |
264,107
-3,424
| -1% | -$1.63M | 2.18% | 4 |
|
|
2017
Q2 | $131M | Sell |
267,531
-11,063
| -4% | -$4.84M | 2.53% | 2 |
|
|
2017
Q1 | $108M | Sell |
278,594
-8,329
| -3% | -$3.09M | 2.06% | 4 |
|
|
2016
Q4 | $105M | Sell |
286,923
-19,060
| -6% | -$7.25M | 2.13% | 4 |
|
|
2016
Q3 | $123M | Sell |
305,983
-3,454
| -1% | -$1.39M | 2.47% | 2 |
|
|
2016
Q2 | $108M | Buy |
309,437
+620
| +0.2% | +$239K | 2.33% | 3 |
|
|
2016
Q1 | $111M | Buy |
308,817
+5,604
| +2% | +$2.31M | 2.38% | 3 |
|
|
2015
Q4 | $165M | Sell |
303,213
-14,552
| -5% | -$7.88M | 3.45% | 1 |
|
|
2015
Q3 | $148M | Sell |
317,765
-54,474
| -15% | -$29.3M | 3.27% | 1 |
|
|
2015
Q2 | $190M | Sell |
372,239
-42,004
| -10% | -$20.5M | 3.53% | 1 |
|
|
2015
Q1 | $187M | Sell |
414,243
-36,887
| -8% | -$15.6M | 3.49% | 1 |
|
|
2014
Q4 | $185M | Sell |
451,130
-9,560
| -2% | -$3.76M | 3.63% | 1 |
|
|
2014
Q3 | $166M | Sell |
460,690
-55,273
| -11% | -$18.5M | 3.38% | 1 |
|
|
2014
Q2 | $146M | Sell |
515,963
-29,638
| -5% | -$8.78M | 2.84% | 1 |
|
|
2014
Q1 | $164M | Sell |
545,601
-17,899
| -3% | -$5.51M | 3.19% | 1 |
|
|
2013
Q4 | $155M | Sell |
563,500
-44,118
| -7% | -$12.7M | 3.03% | 1 |
|
|
2013
Q3 | $190M | Sell |
607,618
-15,584
| -3% | -$4.1M | 3.93% | 1 |
|
|
2013
Q2 | $140M | Buy |
+623,202
| New | +$145M | 3.15% | 1 |
|
Other funds holding REGN
VCM
N
Pinnacle Associates's REGN Position: Q1 2026 in Review
Pinnacle Associates reduced its Regeneron Pharmaceuticals (REGN) stake by 1.5% in Q1 2026, selling an estimated $941K and leaving 82,512 shares worth $63.8M. The position accounts for 0.82% of the portfolio, ranked #23.
Pinnacle Associates first reported a position in REGN in Q2 2013 and has held it in 52 quarters since. The position peaked at $190M in Q3 2013. 1,393 funds tracked by Wall St. Rank hold REGN as of Q1 2026.
- Pinnacle Associates held 82,512 shares of Regeneron Pharmaceuticals worth $63.8M as of Q1 2026.
- Pinnacle Associates sold 1,229 Regeneron Pharmaceuticals shares in Q1 2026, an estimated $941K.
- Regeneron Pharmaceuticals made up 0.82% of Pinnacle Associates's portfolio in Q1 2026, its #23 holding.
- Pinnacle Associates first reported a position in Regeneron Pharmaceuticals in Q2 2013 and has held it in 52 quarters since.
- Pinnacle Associates's Regeneron Pharmaceuticals position peaked at $190M in Q3 2013.
- 1,393 funds tracked by Wall St. Rank held Regeneron Pharmaceuticals as of Q1 2026.
Based on Pinnacle Associates's 13F filing for Q1 2026, filed 22 Apr 2026.